tiprankstipranks
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
US Market

Xvivo Perfusion AB (XVIPF) Income Statement

Compare
10 Followers

Xvivo Perfusion AB Income Statement

Last quarter (Q4 2024), Xvivo Perfusion AB's total revenue was kr227.56M, an increase of 46.12% from the same quarter last year. In Q4, Xvivo Perfusion AB's net income was kr36.39M. See Xvivo Perfusion AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 822.41Mkr 597.54Mkr 415.29Mkr 258.39Mkr 179.86M
Gross Profit
kr 616.41Mkr 445.11Mkr 296.96Mkr 188.28Mkr 132.97M
Operating Expenses
kr 528.06Mkr 440.92Mkr 292.50Mkr 207.02Mkr 167.29M
Depreciation and Amortization
kr 0.00kr 30.86Mkr 15.80Mkr 32.26Mkr 13.37M
EBITDA
kr 88.35Mkr 126.57Mkr 39.21Mkr 39.20Mkr -43.33M
Operating Income
kr 88.35Mkr 4.19Mkr 23.18Mkr 6.98Mkr -34.31M
Other Income/Expenses
kr 111.59Mkr 90.33Mkr -867.00Kkr -317.00Kkr -11.59M
Pretax Income
kr 199.95Mkr 94.52Mkr 22.31Mkr 6.67Mkr -57.26M
Net Income
kr 172.18Mkr 91.82Mkr 18.43Mkr 8.15Mkr -43.73M
Per Share Metrics
Basic EPS
kr 5.47kr 3.07kr 0.62kr 0.28kr -1.61
Diluted EPS
kr 5.44kr 3.07kr 0.62kr 0.28kr -1.61
Weighted Average Shares Outstanding
31.50M 29.94M 29.53M 28.85M 27.17M
Weighted Average Shares Outstanding (Diluted)
31.67M 29.94M 29.53M 28.94M 27.17M
Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis